Differential expression of PACAP receptors in postnatal rat brain

Neuropeptides

Volumn 44, Issue 6, 2010, Pages 509-514

  Shneider, Yevgenia ^a,b   Shtrauss, Yael ^a   Yadid, Gal ^b   Pinhasov, Albert ^a  

^a ARIEL UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Cortex; Hippocampus; PAC1; PACAP; Postnatal development; Striatum; VIP; VPAC1; VPAC2

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MALE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; FEMALE; MALE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

RATTUS;

EID: 78349307653     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.09.001     Document Type: Article

References (47)

1. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991, 129:2787-2789.
2. Atlasz T., Szabadfi K., Kiss P., Babai N., Koszegi Z., Tamas A., Reglodi D., Gabriel R. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration. J. Mol. Neurosci. 2008, 36:97-104.
3. Babai N., Atlasz T., Tamas A., Reglodi D., Toth G., Kiss P., Gabriel R. Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina. Ann. N. Y. Acad. Sci. 2006, 1070:149-155.
4. Bremner J.D., Vythilingam M., Vermetten E., Nazeer A., Adil J., Khan S., Staib L.H., Charney D.S. Reduced volume of orbitofrontal cortex in major depression. Biol. Psychiatry 2002, 51:273-279.
5. Chen Y., Samal B., Hamelink C.R., Xiang C.C., Chen M., Vaudry D., Brownstein M.J., Hallenbeck J.M., Eiden L.E. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Pept. 2006, 137:4-19.
6. Daniel P.B., Kieffer T.J., Leech C.A., Habener J.F. Novel alternatively spliced exon in the extracellular ligand-binding domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) selectively increases ligand affinity and alters signal transduction coupling during spermatogenesis. J. Biol. Chem. 2001, 276:12938-12944.
7. Dautzenberg F.M., Mevenkamp G., Wille S., Hauger R.L. N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J. Neuroendocrinol. 1999, 11:941-949.
8. Dickson L., Finlayson K. VPAC and PAC receptors: From ligands to function. Pharmacol. Ther. 2009, 121:294-316.
9. Dmitrieva N.I., Semenova T.P., Uteshev V.K. Dimensions of the hippocampus, memory, and learning in the ontogenesis of rats. Neurosci. Behav. Physiol. 1977, 8:321-326.
10. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
11. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54:597-606.
12. Hammack S.E., Cheung J., Rhodes K.M., Schutz K.C., Falls W.A., Braas K.M., May V. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 2009, 34:833-843.
13. Hashimoto H., Shintani N., Tanaka K., Mori W., Hirose M., Matsuda T., Sakaue M., Miyazaki J., Niwa H., Tashiro F., Yamamoto K., Koga K., Tomimoto S., Kunugi A., Suetake S., Baba A. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl Acad. Sci. USA 2001, 98:13355-13360.
14. Hashimoto R., Hashimoto H., Shintani N., Chiba S., Hattori S., Okada T., Nakajima M., Tanaka K., Kawagishi N., Nemoto K., Mori T., Ohnishi T., Noguchi H., Hori H., Suzuki T., Iwata N., Ozaki N., Nakabayashi T., Saitoh O., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Kunugi H., Baba A. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol. Psychiatry 2007, 12:1026-1032.
15. Jarrard L.E. On the role of the hippocampus in learning and memory in the rat. Behav. Neurol. Biol. 1993, 60:9-26.
16. Journot L., Spengler D., Pantaloni C., Dumuis A., Sebben M., Bockaert J. The PACAP receptor: generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells. Semin. Cell Biol. 1994, 5:263-272.
17. Kamnasaran D. Genetic analysis of psychiatric disorders associated with human chromosome 18. Clin. Invest. Med. 2003, 26:285-302.
18. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69:113-132.
19. Li M., Mbikay M., Arimura A. Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology 2000, 141:3723-3730.
20. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989, 164:567-574.
21. Nachkebiia N.G., Oniani T.N. Effect of functional elimination of the hippocampus on learning and memory. Fiziol. Zh. 1985, 31:385-392.
22. Nguyen T.D., Heintz G.G., Wolfe M.S. Structural characterization of PACAP receptors on rat liver plasma membranes. Am. J. Physiol. 1993, 265:G811-818.
23. O'Hearn K., Asato M., Ordaz S., Luna B. Neurodevelopment and executive function in autism. Dev. Psychopathol. 2008, 20:1103-1132.
24. Ohtaki H., Nakamachi T., Dohi K., Shioda S. Role of PACAP in ischemic neural death. J. Mol. Neurosci. 2008, 36:16-25.
25. Onoue S., Endo K., Ohshima K., Yajima T., Kashimoto K. The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 2002, 23:1471-1478.
26. Pilzer I., Gozes I. VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new neuroprotection target. Peptides 2006, 27:2867-2876.
27. Rangon C.M., Goursaud S., Medja F., Lelievre V., Mounien L., Husson I., Brabet P., Jegou S., Janet T., Gressens P. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. J. Pharmacol. Exp. Ther. 2005, 314:745-752.
28. Reglodi D., Somogyvari-Vigh A., Vigh S., Kozicz T., Arimura A. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 2000, 31:1411-1417.
29. Reichenstein M., Rehavi M., Pinhasov A. Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J. Mol. Neurosci. 2008, 36:330-338.
30. Sanches M., Keshavan M.S., Brambilla P., Soares J.C. Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1617-1627.
31. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160:1516-1518.
32. Shen Y., Specht S.M., De Saint Ghislain I., Li R. The hippocampus: a biological model for studying learning and memory. Prog. Neurobiol. 1994, 44:485-496.
33. Sheward W.J., Lutz E.M., Harmar A.J. Expression of pituitary adenylate cyclase activating polypeptide receptors in the early mouse embryo as assessed by reverse transcription polymerase chain reaction and in situ hybridisation. Neurosci. Lett. 1996, 216:45-48.
34. Shioda S., Ohtaki H., Nakamachi T., Dohi K., Watanabe J., Nakajo S., Arata S., Kitamura S., Okuda H., Takenoya F., Kitamura Y. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann. N. Y. Acad. Sci. 2006, 1070:550-560.
35. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993, 365:170-175.
36. Stumm R., Kolodziej A., Prinz V., Endres M., Wu D.F., Hollt V. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J. Neurochem. 2007, 103:1666-1681.
37. Tatsuno I., Gottschall P.E., Koves K., Arimura A. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes. Biochem. Biophys. Res. Commun. 1990, 168:1027-1033.
38. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994, 135:2662-2680.
39. Vaudry D., Gonzalez B.J., Basille M., Fournier A., Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl Acad. Sci. USA 1999, 96:9415-9420.
40. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 2000, 52:269-324.
41. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 2009, 61:283-357.
42. Vita A., Dieci M., Giobbio G.M., Tenconi F., Invernizzi G. Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. Schizophr. Res. 1997, 23:25-30.
43. Waschek J.A. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev. Neurosci. 2002, 24:14-23.
44. Waschek J.A., Casillas R.A., Nguyen T.B., DiCicco-Bloom E.M., Carpenter E.M., Rodriguez W.I. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc. Natl Acad. Sci. USA 1998, 95:9602-9607.
45. Watanabe J., Ohba M., Ohno F., Kikuyama S., Nakamura M., Nakaya K., Arimura A., Shioda S., Nakajo S. Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C. J. Neurosci. Res. 2006, 84:1645-1655.
46. Zhou C.J., Shioda S., Shibanuma M., Nakajo S., Funahashi H., Nakai Y., Arimura A., Kikuyama S. Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage. Neuroscience 1999, 93:375-391.
47. Zhou C.J., Kikuyama S., Nakajo S., Arimura A., Shioda S. Ontogeny of PACAP receptor and its splice variants in the rat brain. Ann. N. Y. Acad. Sci. 2000, 921:375-376.